These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 7201844

  • 1. Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma.
    Baron M, Skrinskas G, Hyland R, Urowitz MB.
    Br Heart J; 1982 Sep; 48(3):304-5. PubMed ID: 7201844
    [No Abstract] [Full Text] [Related]

  • 2. Prostaglandin E1 therapy for digital ulcers in scleroderma.
    Baron M, Skrinskas G, Urowitz MB, Madras PN.
    Can Med Assoc J; 1982 Jan 01; 126(1):42-5. PubMed ID: 7199370
    [No Abstract] [Full Text] [Related]

  • 3. Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension.
    Watkins WD, Peterson MB, Crone RK, Shannon DC, Levine L.
    Lancet; 1980 May 17; 1(8177):1083. PubMed ID: 6103414
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of severe Raynaud's phenomenon with prostaglandin E1.
    Allen JA, O'Reilly MJ.
    Ir J Med Sci; 1981 Jun 17; 150(6):190-1. PubMed ID: 7275566
    [No Abstract] [Full Text] [Related]

  • 5. Cyclic adenine nucleotide levels in lymphocytes from patients with systemic sclerosis: efficiency of prostaglandin infusions.
    Kovacs IB, Dowd PM, Kirby JD, Turner P.
    Postgrad Med J; 1983 Apr 17; 59(690):241-3. PubMed ID: 6306626
    [Abstract] [Full Text] [Related]

  • 6. [Postoperative management of a case of SLE and mitral stenosis combined with severe pulmonary hypertension: effect of prostaglandin E1].
    Atsumi N, Mizuhara A, Sakai A, Tsutsui T, Okamura K, Maeta H, Ijima H, Mitsui T, Hori M, Doi M.
    Kokyu To Junkan; 1987 Oct 17; 35(10):1099-103. PubMed ID: 3423442
    [No Abstract] [Full Text] [Related]

  • 7. [Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
    Phlippoteau C, Brenot F, Blétry O, Simmonneau G, Duroux P.
    Rev Mal Respir; 1990 Oct 17; 7(3):249-54. PubMed ID: 2114030
    [Abstract] [Full Text] [Related]

  • 8. Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension.
    Szczeklik J, Dubiel JS, Mysik M, Pyzik Z, Krol R, Horzela T.
    Br Heart J; 1978 Dec 17; 40(12):1397-401. PubMed ID: 737098
    [Abstract] [Full Text] [Related]

  • 9. Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis.
    Martin MF, Tooke JE.
    Br Med J (Clin Res Ed); 1982 Dec 11; 285(6356):1688-90. PubMed ID: 6816332
    [Abstract] [Full Text] [Related]

  • 10. [Therapeutic effects of prostaglandin E1 on 59 cases of heart dysfunction].
    Zhang LS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Mar 11; 13(1):35-7. PubMed ID: 4040007
    [No Abstract] [Full Text] [Related]

  • 11. Scleroderma: therapeutic options.
    Connolly SM.
    Cutis; 1984 Sep 11; 34(3):274-6. PubMed ID: 6386354
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic effects of prostaglandin E1 on experimentally induced atherosclerosis].
    Wang TL.
    Zhonghua Yi Xue Za Zhi; 1985 Jan 11; 65(1):13-6. PubMed ID: 2983846
    [No Abstract] [Full Text] [Related]

  • 13. Effects of vasodilators prostaglandin E1 and methylprednisolone on pulmonary hypertension and right ventricular performance during volume loading in porcine septic shock: a combined invasive and radionuclide study.
    Schneider AJ, Teule GJ, Kester AD, van Halderen P, Groeneveld AB, Heidendal GA, Thijs LG.
    Circ Shock; 1987 Jan 11; 22(2):141-54. PubMed ID: 3297378
    [Abstract] [Full Text] [Related]

  • 14. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
    Humbert M.
    Rev Med Interne; 2007 Dec 11; 28 Suppl 4():S273-6. PubMed ID: 17961866
    [No Abstract] [Full Text] [Related]

  • 15. Prostaglandin E1. A new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement.
    D'Ambra MN, LaRaia PJ, Philbin DM, Watkins WD, Hilgenberg AD, Buckley MJ.
    J Thorac Cardiovasc Surg; 1985 Apr 11; 89(4):567-72. PubMed ID: 4039017
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E1 restores the levels of vWF and ACE in chronic critical limb ischemia in systemic sclerosis.
    Pignone A, Generini S, Matucci Cerinic M.
    Clin Exp Rheumatol; 2001 Apr 11; 19(3):358-9. PubMed ID: 11407102
    [No Abstract] [Full Text] [Related]

  • 17. Prostaglandin E1 in primary pulmonary hypertension.
    Swan PK, Tibballs J, Duncan AW.
    Crit Care Med; 1986 Jan 11; 14(1):72-3. PubMed ID: 3940758
    [No Abstract] [Full Text] [Related]

  • 18. Postsurgical Hypergranulation and Lymphadenopathy in the Setting of Vasodilator Therapy for Scleroderma-Associated Pulmonary Arterial Hypertension.
    Michalski BM, Sorensen EP, Hurst EA, Jones HA.
    Dermatol Surg; 2021 Mar 01; 47(3):436-437. PubMed ID: 32205747
    [No Abstract] [Full Text] [Related]

  • 19. Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease.
    Naeije R, Mélot C, Mols P, Hallemans R.
    Am Rev Respir Dis; 1982 Jan 01; 125(1):1-5. PubMed ID: 6802045
    [Abstract] [Full Text] [Related]

  • 20. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N, McAlpine L, Peacock AJ, Madhok R.
    Arthritis Rheum; 1998 Mar 01; 41(3):466-9. PubMed ID: 9506575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.